Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 136.00% and Operating profit at 0% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
Risky - Negative Book Value
Stock DNA
Miscellaneous
INR 93 Cr (Micro Cap)
185.00
32
0.00%
-1.61
-14.00%
-92.74
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Sep-20-2013
Risk Adjusted Returns v/s 
Returns Beta
News

Covidh Technologies Ltd is Rated Sell
Covidh Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 Jul 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 77.49
After a sustained rally spanning 21 consecutive trading sessions, Covidh Technologies Ltd surged to a new 52-week high of Rs 77.49 on 28 Apr 2026, marking a remarkable 49.05% gain over this period. This milestone reflects a powerful momentum shift underpinned by a confluence of bullish technical indicators across multiple timeframes.
Read More
Broad-Based Technical Strength Lifts Covidh Technologies Ltd to 52-Week High of Rs 76.99
After a sustained rally spanning 21 consecutive trading sessions, Covidh Technologies Ltd surged to a new 52-week high of Rs 76.99 on 27 Apr 2026, marking a remarkable 51.02% gain over this period and signalling robust momentum across multiple technical indicators.
Read More Announcements 
Board Meeting Outcome for Outcome Of The Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) Held On Wednesday June 11 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Reg
11-Jun-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) was held on Wednesday June 11 2026. The following businesses were transacted at the aforesaid Board Meeting:
Announcement under Regulation 30 (LODR)-Newspaper Publication
25-May-2026 | Source : BSEWe hereby submit the Newspaper Advertisement for the financial result for the year and quarter ended March 31 2026
Shareholder Meeting / Postal Ballot-Scrutinizers Report
22-May-2026 | Source : BSEWe are hereby submitting the Scrutinizers Report for the postal ballot.
Corporate Actions 
No Upcoming Board Meetings
Covidh Technologies Ltd has declared 5% dividend, ex-date: 20 Sep 13
No Splits history available
No Bonus history available
Covidh Technologies Ltd has announced 25:1 rights issue, ex-date: 24 Oct 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Dhairyasheel Vasantrao Yadav (13.26%)
Neville Maneckji (4.31%)
35.7%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
Not Applicable: The company has declared_date for only one period
Not Applicable: The company has declared_date for only one period
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs 33.33% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -222.22% vs -117.31% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
YoY Growth in year ended Mar 2026 is 116.67% vs 220.00% in Mar 2025